| SWOG/ Support |
STUDY | R E G |
O P E N |
ARM | ACCR. GOAL |
TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SWOG | S2012-Extrapulm NEC, Stg IV, Combo Chemo +/- Atezo | 1 | Y | 1 Platinum/Etoposide + Atezo Induction + Maintenance | 189 | 60 | 14 | 5 | 3 | 2 | 0 | 06/28/2022 | 275 | 82 |
| 2 Platinum/Etoposide + Atezo Induction | 53 | 12 | 3 | 0 | 0 | 0 | ||||||||
| 3 Platinum/Etoposide Only | 58 | 18 | 9 | 1 | 0 | 0 | ||||||||
| 171 | 44 | 17 | 4 | 2 | 0 | |||||||||
| SN2426-cSCC, IC Met/Inop, Amivantamab v Cetuximab | 1 | Y | 1 Amivantamab and hyaluronidase (Safety Run-in) | 86 | 11 | 11 | 6 | 3 | 0 | 0 | 03/23/2026 | 126 | 36 | |
| 3 Cetuximab | 2 | 2 | 2 | 2 | 2 | 1 | ||||||||
| 13 | 13 | 8 | 5 | 2 | 1 | |||||||||
| 21CTP.HN01-HN, Recur/Met, Amivantamab + Chemo | 1 | Y | 1 Amivantamab + Carboplatin + Paclitaxel | 50 | 14 | 14 | 11 | 6 | 4 | 1 | 03/25/2026 | |||
| 14 | 14 | 11 | 6 | 4 | 1 | |||||||||
| Yes | A071401-Prog Meningiomas,SMO/AKT/NF2 Inhib | 0 | E | Total Registrations | 54 | 2 | 1 | 1 | 1 | 0 | 02/22/2016 | 309 | 88 | |
| 54 | 2 | 1 | 1 | 1 | 0 | |||||||||
| 1 | E | Total Registrations | 9 | 0 | 0 | 0 | 0 | 0 | 02/22/2016 | |||||
| 9 | 0 | 0 | 0 | 0 | 0 | |||||||||
| No | A072301-Brain, Stg 3 Astro, +/- Vorasidenib | 0 | E | Total Registrations | 1 | 1 | 1 | 1 | 0 | 0 | 10/09/2026 | 18 | 5 | |
| 1 | 1 | 1 | 1 | 0 | 0 | |||||||||
| 1 | E | Total Registrations | 1 | 1 | 1 | 1 | 1 | 0 | 10/09/2026 | |||||
| 1 | 1 | 1 | 1 | 1 | 0 | |||||||||
| AGCT1531-Mult, Stg I-IV, Carbo vs Cisp, Ped &Adult | 1 | E | Total Registrations | 7 | 3 | 2 | 2 | 2 | 0 | 10/07/2021 | 222 | 114 | ||
| 7 | 3 | 2 | 2 | 2 | 0 | |||||||||
| AGCT1532-Inter/Poor Met GCTs, Accel v Std BEP Chemo | 1 | T | Total Registrations | 5 | 0 | 0 | 0 | 0 | 0 | 12/13/2019 | 214 | 91 | ||
| 5 | 0 | 0 | 0 | 0 | 0 | |||||||||
| EA7211-Sarc, Hi-Risk RetroPeritoneal, Neo+Sur | 1 | E | Total Registrations | 2 | 2 | 0 | 0 | 0 | 0 | 03/24/2026 | 94 | 16 | ||
| 2 | 2 | 0 | 0 | 0 | 0 | |||||||||
| EAY191-ComboMATCH | 1 | E | Total Registrations | 22 | 1 | 1 | 0 | 0 | 0 | 08/03/2023 | 325 | 118 | ||
| 22 | 1 | 1 | 0 | 0 | 0 | |||||||||
| Study | Registration/Phase | Open Date | # of ACT. INSTs |
# of CURR IRBs |
|---|---|---|---|---|
| S2505 Sarcoma, Stg II-IIIB, Surg + Short vs Std RT | 1 Randomization | 06-Jul-26 | 81 | 37 |
| AGCT1531 Mult, Stg I-IV, Carbo vs Cisp, Ped &Adult | 2 Late Randomization Callback | 08-May-17 | 222 | 114 |
| EAY191 ComboMATCH | 2 Re-Screening | 06-Mar-23 | 325 | 118 |